A post marketing study to evaluate safety and effectiveness of Remogliflozin and Remogliflozin-Metformin Combination in treatment of Diabetes patients

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2019
This article has no abstract
Epistemonikos ID: 081ee9ead70a75d41a064483fb221130872b6427
First added on: Apr 08, 2025